Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 7/20 | 0.72 |
| ▸ | CYP1B1 | Q16678 | 7/20 | 0.72 |
| ▸ | NQO2 | P16083 | 5/20 | 0.72 |
| ▸ | ESR1 | P03372 | 4/20 | 0.72 |
| ▸ | TTR | P02766 | 4/20 | 0.72 |
| ▸ | AHR | P35869 | 3/20 | 0.72 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.72 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.72 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.72 |
| ▸ | ABL1 | P00519 | 2/20 | 0.72 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.72 |
| ▸ | BCR | P11274 | 2/20 | 0.72 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.72 |
| ▸ | TUBB4A | P04350 | 2/20 | 0.72 |
| ▸ | TUBB | P07437 | 2/20 | 0.72 |
| ▸ | TUBA3C | P0DPH7 | 2/20 | 0.72 |
| ▸ | TUBA1B | P68363 | 2/20 | 0.72 |
| ▸ | TUBA4A | P68366 | 2/20 | 0.72 |
| ▸ | TUBB4B | P68371 | 2/20 | 0.72 |
| ▸ | TUBB3 | Q13509 | 2/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL392666 | 1.00 | CYP1A1 (0.72) | CYP1A1CYP1B1NQO2ESR1TTR | |
| Trismethoxyresveratrol SCHEMBL918739 | 0.85 | CYP1A1 (1.00) | CYP1A1CYP1B1NQO2ESR1TTR | |
| 8Z-3,4',5-Trimethoxystilbene SCHEMBL1006207 | 0.85 | CYP1A1 (1.00) | CYP1A1CYP1B1NQO2ESR1TTR | |
| Trismethoxyresveratrol SCHEMBL918740 | 0.85 | CYP1A1 (1.00) | CYP1A1CYP1B1NQO2ESR1TTR | |
| SCHEMBL20024678 | 0.84 | ALDH1A3 (0.68) | CYP1A1CYP1B1NQO2ESR1TTR | |
| SCHEMBL27224302 | 0.82 | ESR1 (0.65) | CYP1A1CYP1B1NQO2ESR1TTR | |
| SCHEMBL13443549 | 0.81 | CYP1A1 (0.91) | CYP1A1CYP1B1NQO2ESR1TTR | |
| SCHEMBL3758141 | 0.81 | CYP1A1 (0.91) | CYP1A1CYP1B1NQO2ESR1TTR | |
| SCHEMBL7192552 | 0.80 | CYP1A1 (0.54) | CYP1A1CYP1B1NQO2ESR1TTR | |
| SCHEMBL7192549 | 0.80 | CYP1A1 (0.54) | CYP1A1CYP1B1NQO2ESR1TTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2202215-B1 | Novel process for the synthesis of (E)-Stilbene derivatives which makes it possible to obtain resveratrol and piceatannol | CLARIANT SPECIALTY FINE CHEM F (FR) | 2013-10-02 | — | — | EP | disclosed |
| EP-2049459-B1 | NOVEL PROCESS FOR THE SYNTHESIS OF (E)-STILBENE DERIVATIVES WHICH MAKES IT POSSIBLE TO OBTAIN RESVERATROL AND PICEATANNOL | CLARIANT SPECIALTY FINE CHEM F (FR) | 2013-10-02 | — | — | EP | disclosed |
| US-8101804-B2 | Process for the synthesis of (E)-stilbene derivatives which makes it possible to obtain resveratrol and piceatannol | CLARIANT SPECIALTY FINE CHEMICALS (FRANCE) (FR) | 2012-01-24 | — | — | US | disclosed |
| EP-2202215-A2 | Novel process for the synthesis of (E)-Stilbene derivatives which makes it possible to obtain resveratrol and piceatannol | Clariant Specialty Fine Chemicals (France) (FR) | 2010-06-30 | — | — | EP | disclosed |
| US-20100004483-A1 | Novel Process For The Synthesis Of (E)-Stilbene Derivatives Which Makes It Possible To Obtain Resveratrol And Piceatannol | CLARIANT SPECIALTY FINE CHEMICALS (FRANCE) (FR) | 2010-01-07 | — | — | US | disclosed |
| EP-2049459-A1 | NOVEL PROCESS FOR THE SYNTHESIS OF (E)-STILBENE DERIVATIVES WHICH MAKES IT POSSIBLE TO OBTAIN RESVERATROL AND PICEATANNOL | Clariant Specialty Fine Chemicals (France) (FR) | 2009-04-22 | — | — | EP | disclosed |
| WO-2008012321-A1 | NOVEL PROCESS FOR THE SYNTHESIS OF (E)-STILBENE DERIVATIVES WHICH MAKES IT POSSIBLE TO OBTAIN RESVERATROL AND PICEATANNOL | CLARIANT SPECIALTY FINE CHEMICALS (FRANCE) (FR) | 2008-01-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100004483-A1 | Novel Process For The Synthesis Of (E)-Stilbene Derivatives Which Makes It Possible To Obtain Resveratrol And Piceatannol | SQLE, SUCLA2, SORD | CYP1A1 302/4885CYP1B1 218/4885NQO2 1082/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.